SmartLabs’ Brian Taylor Selected as PharmaVoice 100 Honoree
SmartLabs is proud to announce that CEO Brian Taylor has been honored by the PharmaVoice 100 as one of the top leaders in life sciences industry. With over 20 years of experience, Taylor has been instrumental in driving innovation since joining SmartLabs in 2020. Now, as CEO, he continues to steer the company toward strategic growth while advancing its mission to enable groundbreaking scientific discoveries.
March 21,2025
Boston, MA, October 8, 2024 – Brian Taylor, CEO of SmartLabs has been selected as a PharmaVoice 100 honoree in the “Biotech Pathfinders” category in recognition of his 20-plus years of dedication and impact in the life sciences industry. This annual list highlights the most inspiring people in the life sciences industry.
“It is an honor to be included alongside so many influential and inspiring leaders in the industry,” said Brian Taylor. “This recognition reflects the hard work and dedication of both the SmartLabs’ team and our member companies as we push the boundaries of scientific innovation together. I’m excited for what lies ahead as we continue to advance bespoke resourcing and infrastructure solutions, enabling researchers to bring groundbreaking therapies to the patients who need them most.”
A 25-year veteran of the pharmaceutical industry, Taylor held key leadership positions at a number of biotech organizations before joining SmartLabs in 2020 as the Executive Vice President of Biopharma Solutions. In this role he oversaw the company’s technical and site operations and commercial responsibilities, led all lobbying activities, and built a dedicated group responsible for developing SmartLabs’ innovative new service offerings. Now as CEO, he continues to act as a driving force of innovation, setting the direction for SmartLabs’ next phase of strategic growth as the company works to deliver on its goal to accelerate the pace of scientific breakthroughs for everyone, everywhere.
PharmaVoice100 honorees are selected from a pool of nominations submitted by readers and colleagues, evaluated by the PharmaVoice team, then categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions, and Cell and Gene Therapy Pioneers. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way.
“These honorees are inspirations. Their teams look to them for guidance, their patients for support, and their organizations for direction. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements. We are excited to recognize their contributions through this annual list,” said Meagan Parrish, lead editor of PharmaVoice. Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only awards program in the industry that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.
Read more about Taylor’s recognition here.